Building an Integrated, End-to-End R&D and Manufacturing Service Platform with Innovative R&D and High-end Preparation Technologies
Frost & Sullivan Manufacturing
DECEMBER 25, 2024
This category includes novel injectable delivery systems like liposomes and nanoformulations, as well as immediate-release oral dosage forms and transdermal drug delivery systems. Additionally, the company has established 14 drug delivery platforms, covering various dosage forms such as cataplasms and blow-fill-seal (BFS) eye drops.
52 
Let's personalize your content